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Abstract
A commercial semi‐empirical volumetric dose verification system (PerFraction [PF],
Sun Nuclear Corp.) extracts multi‐leaf collimator positions from the electronic portal
imaging device movies collected during a pre‐treatment run, while the rest of the
delivered control point information is harvested from the accelerator log files. This
combination is used to reconstruct dose on a patient CT dataset with a fast super-
position/convolution algorithm. The method was validated for single‐isocenter multi‐
target SRS VMAT treatments against absolute radiochromic film measurements in a
cylindrical phantom. The targets ranged in size from 0.8 to 3.6 cm and in number
from 3 to 10 per plan. A total of 17 films rotated at different angles around the
cylinder axis were analyzed. Each of 27 total targets was intercepted by at least one
film, and 2–4 different films were analyzed per plan. Film dose was always scaled to
the ion chamber measurement in a high‐dose, low‐gradient area deliberately created
at the isocenter. The planar dose agreement between PF and film using 3%(Global
dose‐difference normalization)/1 mm gamma analysis was on average 99.2 ± 1.1%.
The point dose difference in the low‐gradient area in the middle of every target was
below 3%, while PF‐reconstructed and film dose centroids for individual targets
showed submillimeter agreement when measured on a well aligned accelerator. Vol-
umetrically, all voxels in all plans agreed between PF and the primary treatment
planning system at the 3%/1 mm level. With proper understanding of its advantages
and shortcomings, the tool can be applied to patient‐specific QA in routine radiosur-
gical clinical practice.
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1 | INTRODUCTION
Brain metastases are a common oncological diagnosis1 and intracra-
nial stereotactic radiosurgery (SRS) has evolved as an important
modality of treatment/palliation for that disease.2,3 It was demon-
strated that even with multiple metastases the SRS treatment could
provide reasonable local control,4,5 and a multi‐institutional observa-
tional study suggested that clinical outcomes for patients with 5–10
individual metastases treated by SRS alone may be non‐inferior to
those with 2–4 targets.6,7 While conceptually straightforward in prin-
ciple, multi‐target SRS poses logistical challenges. As the number of
treated metastases increases, the traditional SRS paradigm of one
isocenter per lesion leads to prohibitively long treatment times and
had to be revisited with the goal of simultaneously treating multiple
targets. Interestingly, while dynamic conformal arcs were the main-
stay of linac‐based radiosurgery for years, the feasibility of single‐iso-
center multiple‐target (SIMT) approach was first demonstrated with
a relatively new volumetric modulated arc therapy (VMAT) tech-
nique.8,9 The most recent commercial implementation (HyperArc,
Varian Medical Systems) offers refinements in terms of planning
automation and collision prevention.10 Alternatively, Huang et al.11
proposed a concept of single isocenter dynamic conformal arcs
(SIDCA), whereby each lesion is treated by a dedicated group of
dynamic conformal arcs but all groups share the same isocenter posi-
tioned between all targets. This allows for more efficient dynamic
arc treatment, as only one isocenter setup is necessary, and the
couch angles and arc directions can be optimized for fastest delivery.
A version of SIDCA is commercially implemented in Automatic Brain
Metastases Planning Element software by BrainLab.12,13 It creates a
series of dynamic arcs and each lesion can be covered by all or some
of them, depending on the relative position, to minimize normal tis-
sue irradiation. Both techniques by necessity produce treatment
plans containing complex MLC apertures, and it is prudent to per-
form patient‐specific end‐to‐end test prior to commencing the treat-
ment.14 The number of small, off‐center targets poses a unique
challenge to dosimetry devices commonly used for such tests. The
approach should possess high spatial resolution as the lesions could
be of the order of 1 cm or less in size. At the same time, the targets
could be fairly wide spread, which negates the advantages of dedi-
cated “stereotactic” detector arrays with small detector pitch, that
typically have a relatively small active area under the assumption
that the lesion would be located at isocenter.15 Moreover, the tar-
gets randomly placed in three dimensions naturally call for a 3D veri-
fication approach. The only true 3D dosimeters with high spatial
resolution are radiochromic gels/polymers,16,17 one of which was
successfully used for VMAT‐based SIMT validation.18 However, volu-
metric radiochromic dosimetry is sufficiently cumbersome at this
point to prevent its use for routine patient‐specific quality assur-
ance.19 Therefore, a more practical method is needed that combines
some high spatial resolution measurements with 3D dose recon-
struction over a volume of an adult head. One such approach, which
we validate in this paper, is a hybrid technique whereby information
collected from the accelerator electronic portal imaging device (EPID)
and delivery log files is supplied as input to the independent dose
calculation algorithm that reconstructs the expected deliverable dose
distribution on the patient CT dataset.20
2 | METHODS
2.A | System description
The method evaluated in this paper is a part of PerFRACTION (PF)
software suite (Sun Nuclear Corp, Melbourne, FL) that provides a
number of options for pre‐ and on‐treatment patient‐specific dosi-
metric analysis. We focused on the pre‐treatment patient‐specific
QA (called Fraction 0) and chose the input configuration that, in our
opinion, provided the most advantageous balance between the
empirical and calculation portions of the analysis. The software runs
on a central dedicated Windows server and all routine user interac-
tions occur through a web browser‐based interface. At the heart of
the method is the graphics processing unit‐accelerated superposi-
tion/convolution dose calculation algorithm described and validated
previously.21,22 The beam model can be customized by the vendor
to fit the user's data, although a generic model for the accelerator
class configuration proved sufficient in this work.
The system is compatible with contemporary Varian and Elekta
linacs. The verification process starts with transferring the patient
CT and finalized Plan, Structure, and Dose DICOM RT objects from
the treatment planning system to PF. This establishes a new patient/
plan in the system. The same plan is transferred to the record‐and‐
verify (R&V) system and is then delivered to the EPID operating in a
cine mode. The compressed (MPEG) EPID movies, one per beam, are
stored after the delivery in a specified network directory that is
monitored by PF, automatically transferred to the PF server, and
associated with the individual beam(s) found in the RT Plan object.
The accelerator log files are processed in the exact same fashion.
The EPID image frames are then synchronized to the log files to
determine the exact duration of time when each EPID frame was
acquired. This is achieved by first creating a series of predicted
images based on the projection of the RT Plan fluence to the plane
of the EPID. The predicted images of every segment (or multitude of
segments) are then compared to the measured frames to find the
maximum similarity. The measured frame with maximum similarity is
considered to be acquired during the same segments as the best
matching predicted image.
With the synchronization process completed, the frames are then
analyzed to determine the location of each MLC during that time
period. An edge detection algorithm is used to find the MLC edges
on EPID frames. From this information, an internal RT Plan is
devised, with the control points (CP) created by amalgamation of the
EPID movies and log files. Specifically, the time‐resolved multi‐leaf
collimator (MLC) apertures are derived from the EPID files, indepen-
dent of the accelerator logs. The positions of the rest of the acceler-
ator axes per CP (fractional monitor units (MU), gantry angle, etc.)
are determined from the delivery log files. In addition to MLC posi-
tions, if radiation is detected on regions of the EPID which were
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supposed to be covered by the jaws, corrected jaw positions are
incorporated into the internal RT Plan so that such unexpected radi-
ation is properly accounted for in the final dose calculation. With CP
point information thus complete, the dose calculation is triggered.
The PF calculation voxel size is the larger of the TPS or the mini-
mum set in PF, which was 2.5 mm in this work. This voxel size was
set to obtain a reasonable compromise between the calculation
speed and accuracy and the dose distribution is not distinguishable
from the one calculated with a 2 mm voxel14 at the 1% dose‐differ-
ence/1 mm distance to agreement level. The resulting semi‐empirical
dose distribution can be compared to the planned one by standard
gamma analysis23 and dose‐volume histogram evaluation.
2.B | Planning and delivery
2.B.1 | The phantom
A MultiPlug (Sun Nuclear) phantom is a 15.1 cm diameter Poly
(methyl methacrylate) (PMMA) cylinder, further encased in a PMMA
shell with 26.6 cm outer diameter (Fig. 1). The phantom has inter-
changeable inserts to accommodate either an ion chamber (in this
case, 0.06 cm3 A1SL, Standard Imaging, Middleton, WI) or a
13.2 × 16.5 cm2 piece of radiochromic film. The film insert has small
sharp points at five locations to imprint fiducial marks on the film.
Those were augmented by small amounts of Barium paste to provide
high‐contrast but low‐artifact fiducials for eventual cone‐beam CT
(CBCT) alignment on a linear accelerator. The plug with the film
insert can be freely rotated in the shell around the cylinder axis. The
phantom was scanned on a 16‐slice Big Bore scanner (Philips Medi-
cal, Cleveland, OH) according to our standard SRS protocol (sequen-
tial scans with 1.25 mm slice thickness), with four different film
plane orientations: coronal, sagittal, and ±45° obliques. The plane
angular positions were established directly with a digital level. These
scans served as the baseline datasets for CBCT alignment of the
phantom with the film holder in different orientations.
2.B.2 | Treatment planning
The datasets were transferred to the TPS (Pinnacle v. 14.0, Philips
Radiation Oncology Systems, Fitchburg, WI) and the isocenter was
placed based on the known locations of the film fiducials visible on
CT scans. The next step was devising regions of interest (ROI) for
planning. Six plans of two types were created. The first three plans
in Table 1 contain only three spherical target ROIs each, with the
goal of creating conformal plans without additional constraints. Each
target is intersected in the middle by at least one film plane. Plans
4–6 are rooted in real patient datasets. The patient RT Structure
DICOM objects were processed to make transfer to the phantom
CT possible. The organs‐at‐risk (OAR) had to be moved some to
ensure that they were positioned within the cylinder. The targets
were also nudged to intersect with at least one film plane each. An
example arrangement can be seen in Fig. 1A, which shows the tar-
gets (red) above, below, and intersecting the coronal plane. Two to
four planes were measured per plan. Overall, 17 films intersecting
27 targets were analyzed. In addition to those, each plan contained
a 2 cm diameter spherical structure (green in Fig. 1A) drawn at the
isocenter and planned to achieve uniform 18 Gy dose for normaliza-
tion purposes.
VMAT optimization employed two full coplanar and two partial
(164° rotation) non‐coplanar (±25° table rotation) arcs. The flat
caudal edge of the phantom precluded the use of vertex beams
common in SRS, which however should not affect the generality of
the tests. All plans used A 6 MV flattening filter free beam with
the maximum repetition rate of 1400 MU/min and were calculated
with 2° CP increment and a 2 mm isotropic dose grid resolution.
(a) (b)
F I G . 1 . (a) A CT‐based coronal plane cut through the center of the assembled phantom. The inner cylinder, the outer shell and the film
rectangle in the middle (coronal orientation) can all be appreciated. An example of ROI arrangement is presented, with multiple targets (red),
normal structures (blue) and a central 2 cm target sphere (green) for ion chamber normalization, the latter common to all plans. (b) A
photograph of the MultiPlug with the partially inserted film holder and ion chamber. Note that for the actual measurements the ion chamber
insert replaced film at the isocenter.
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The prescriptions followed RTOG 0320 protocol,24 depending on
the target size: 24 Gy to the planning target volume (PTV) <2 cm,
18 Gy to the PTV between 2.1–3 cm, and 15 Gy to the 3.1–4 cm
PTV. Plans 4‐6 also employed common OAR objectives from the
same protocol.
2.B.3 | Beam delivery
All experiments were performed on a TrueBeam v.2.5 linear accel-
erator (Varian Medical Systems, Palo Alto, CA) equipped with a
standard 120‐leaf Millennium MLC, a 6 degree of freedom (6DOF)
couch, and an aS1000 EPID. The EPID pixel size is 0.39 mm,
which translates into 0.26 mm effective size at isocenter when
the EPID is positioned 150 cm from the source. Prior to measure-
ments the alignment of mechanical, MV, and kV isocenters of the
accelerator were verified by two methods. First, the built‐in IsoCal
verification routine25 was employed. It demonstrated the maximum
MV isocenter deviation of 0.42 mm (with no couch rotation) and
negligible translational and angular misalignment of the kV and
MV imagers. Second, an independent MLC‐based Winston‐Lutz
test with 12 angular combinations covering the full range of accel-
erator motions confirmed the maximum treatment isocenter devia-
tion of 0.41 mm.
The plan information was transferred to the accelerator through
Mosaiq v. 2.4 (Elekta Impac, Sunnyvale, CA) R&V system. Before
delivery, the phantom was first leveled and then aligned in 3D by
CBCT to the film fiducials in the desired plane orientation with the
help of the 6DOF couch.
2.C | Dose comparison
The core of this work is dosimetric comparisons between PF
reconstructed dose and film measurements. The strategy was to
convert the relative dose measured by calibrated film to absolute
by normalization to the ion chamber dose at isocenter. To that
end, the ion chamber reading in the MultiPlug phantom was col-
lected under the standard conditions (parallel‐opposed horizontal
10 × 10 cm2 fields) and converted to dose by comparison with
Pinnacle point dose in the same geometry. Subsequently, an ion
chamber measurement was performed for each plan and the
resulting dose at isocenter was used to scale dose for the films
belonging to that plan.
2.C.1 | Film measurements
Extended range Gafchromic film (EBT‐XD, Ashland Inc., Bridgewater,
NJ) was chosen because of the wide dynamic range,26,27 well‐suited
for SRS verification. An additional benefit is greatly reduced scanner
lateral response artifact.26 Both calibration and measurement film
pieces were scanned in the same orientation with respect to the
original sheet they came from. Templates sized to fit the calibration
(smaller) and measurement films were made out of black paper to
reproducibly position the films in the center of the flatbed document
scanner (Expression 11000XL, Epson Seiko Corporation, Nagano,
Japan). Exposed films were scanned 24 h after irradiation, in trans-
mission mode and without any corrections. Resolution was set at 72
dpi (0.35 mm/pixel). Every film was scanned in the same position and
orientation before the exposure to account for any background non‐
uniformity. Film calibration was performed with a 6MV beam in a
water‐equivalent solid phantom in the dose range from 2 to30 Gy.
The films were analyzed with RIT v.6.6 software (Radiologic
Imaging Technology, Inc., Colorado Springs, CO). The film scans were
transferred to RIT as 48 bit color image files. The background cor-
rection was applied using the built‐in routine. The film fiducials
marks were aligned to the pre‐defined geometric template, and the
dose after application of the calibration curve was further scaled to
match the ion chamber dose at the isocenter. The film dose was
averaged for scaling over 13 central pixels in the craniocaudal direc-
tion, corresponding approximately to the chamber active volume
length. There is no direct interface for importing dose in arbitrary
plane from PF to RIT. Instead, volumetric dose was exported from
PF as a DICOM RT Dose file and then imported to Pinnacle using a
custom script. After that, planar doses in required orientations could
be extracted from Pinnacle on a 1 mm grid using the built‐in IMRT
QA tool and imported into RIT. Three types of tests were performed
using RIT. First, an overall dose comparison was done using gamma
analysis with 3% (global dose‐difference normalization), 1 mm dis-
tance to agreement, and 10% low‐dose cutoff threshold criteria. The
RIT digital gamma analysis routine modeled after Depuydt et al28
was used. For completeness, the same analysis was performed for
Pinnacle. Second, the point doses in the low‐gradient region near
the center of each target were extracted from the film dose profiles
(averaged over 3 pixels, or about 1 mm) and compared to PF. The
distribution of dose‐differences was tested for normality by D'Agos-
tino & Pearson test implemented in GraphPad Prism statistical
TAB L E 1 The plans, target sizes and positions, and film plane orientations. The maximum filed sizes (jaws) for each plan are also presented.
Plan
No. of
Targets Targets max dimensions, cm Target center distance from isocenter, cm
Max. field size
(X × Y), cm2
Measurement
planes orientation
1 3 1.3, 1.2, 2.1 3.6, 5.0, 5.5 10.1 × 12.0 Cor.,Obl.45°,Obl.135°
2 3 1.1, 1.2, 2.4 5.8, 5.9, 6.2 12.7 × 15.0 Cor.,Sag.,Obl.135°
3 3 1.3, 1.2, 2.9 5.5, 4.5, 4.7 11.1 × 13.0 Obl.45°,Obl.135°
4 3 2.2, 1.1, 0.8 4.3, 3.6, 5.4 11.3 × 10.5 Obl.45°,Obl.135°
5 5 2.2, 1.1, 0.8, 3.6, 2.3 4.3, 3.6, 5.4, 4.7, 4.0 10.9 × 12.5 Cor.,Obl.45°,Ob1.135°
6 10 2.2, 1.1, 0.8, 3.6, 2.3, 1.4, 1.4, 0.9, 1.2, 1.1 4.3, 3.6, 5.4, 4.7, 4.0, 4.0, 5.1, 6.3, 3.4, 6.3 12.2 × 12.5 Cor.,Sag.,Obl.45°, Obl.135°
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package (v. 7.0, GraphPad Software, La Jolla, CA). Finally, paramount
to radiosurgical applications, the alignment of measured and recon-
structed profiles at the 50% level (dose centroid) was evaluated.
Horizontal and vertical profiles were drawn in RIT through the cen-
ter of each target on every film image. The vertical profile always
corresponded to the craniocaudal direction. The horizontal profile
anatomical direction varied with film orientation, anywhere from
anteroposterior to lateral, and the results were segregated accord-
ingly. The metric was, in most cases, the difference in the coordi-
nates of the midpoints between the 50% level dose profile points. In
a few instances where the targets were too close to each other to
produce clearly isolated dose peaks on the film, the 65% profile
points were used to calculate the dose centroid.
3. | RESULTS
3.A | Gamma analysis results
The gamma analysis results (3%G/1 mm) are detailed in Table 2.
Excellent agreement is observed for PF, with the lowest passing
rate of 96.1%. Pinnacle results are also solid, although for two
films the passing rate slipped just below 90%. The 95% confidence
intervals were 98.7–99.8% for PF and 95.2–98.4% for Pinnacle,
indicating that both systems can be considered in agreement with
experiment by current standards.29 It is therefore not surprising
that volumetric gamma analysis comparison between the two algo-
rithms demonstrated 100% agreement for all plans at the 3%/
1 mm level.
Fig. 2 illustrates the patterns of gamma analysis failures for the
films with the lower passing rates. While some minor discrepancies
in the target areas are present, the majority of the disagreement for
both PF and Pinnacle, which is already quite small in absolute terms,
is confined to the low‐ or intermediate‐dose regions. The latter are
sometimes prominent when a film plane glances the target and some
of the peripheral target dose is still evident on the film. In that case,
there is a high‐dose gradient in the direction perpendicular to the
film, leading to dosimetric discrepancies due to residual geometric
misalignments. Those errors are not accounted for in the distance‐
to‐agreement since the gamma analysis is performed in two dimen-
sions (the film plane).
3.B | Peak target dose
Both PF and Pinnacle show agreement with measurement largely to
within ±3%, which is satisfactory, particularly for the targets less
than 1 cm in size. For all targets, the average dose‐errors were
−0.4% ± 1.3% (range −2.2 to 2.4%, 99% CI −1.1 to 0.3%) and
0.1% ± 1.6% (range −2.7 to 3.2%, 99% CI −0.8 to 1.0%) for PF and
Pinnacle respectively. Both distributions did not show significant
deviation from normal by the D'Agostino & Pearson normality test (P
≥0.2). There was no correlation between the dose‐error and the tar-
get size (Pearson correlation coefficient r = 0.23 and 0.21 for PF and
Pinnacle, respectively). Similarly, there was no correlation between
the dose‐error and the target distance from isocenter (r = 0.1 and
−0.1 for PF and Pinnacle, respectively).
3.C | Profile alignment
The results of dose profiles alignment between PF and film are
presented in Table 3. Within the range of accelerator motions
employed in the plans, submillimeter average displacements between
the reconstructed and planned dose distribution centroids can
be inferred.
4. | DISCUSSION
While the recent AAPM TG‐218 report29 prescribes the error
thresholds and action levels for gamma analysis comparison between
measured and planned dose distributions, there is no such clear
guidance for purely calculational or semi‐empirical verification. We
chose to retain the 3% dose‐error threshold from TG‐218, which is
also similar to the point‐dose verification recommendations for com-
plex non‐IMRT beams.30 Given the tight SRS spatial accuracy expec-
tations, a 1 mm distance‐to‐agreement threshold seemed desirable.
Finally, the TG‐218 report unequivocally justifies global dose‐error
normalization for routine patient‐specific QA. With these criteria, the
system in question — PerFRACTION — was able to achieve on
average 99.2 ± 1.1% agreement rates with absolute film measure-
ments. Volumetrically, all voxels in all plans agreed between PF and
TAB L E 2 Planar gamma analysis passing rates (3%G/1 mm) for PF
and Pinnacle vs. film.
Plan No. of Targets Planes
Gamma passing rate (%)
PF vs. Film Pinnacle vs. film
100 97.7
Obl.45° 96.1 89.4
Obl.135° 99.1 99.0
2 3 Cor. 100 98.1
Sag. 99.4 95.7
Obl.135° 99.8 99.3
3 3 Obl.45° 100 98.3
Obl.135° 99.9 99.2
4 3 Obl.45° 100 97.1
Obl.135° 100 99.4
5 5 Cor. 99.4 89.9
Obl.45° 99.7 98.6
Obl.135° 97.3 94.5
6 10 Cor. 98.3 94.3
Sag. 99.6 99.0
Obl.45° 99.3 97.5
Obl.135° 99.4 98.4
Ave 99.2 96.8
SD 1.1 3.1
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the TPS at the same 3%/1 mm level. The point doses near the target
center agreed between PF and film to better than 3%, for the target
sizes ranging from 0.8 to 3.6 cm. The reconstructed dose centroid
positions derived from the EPID‐measured MLC apertures on a well‐
aligned accelerator showed on average sub‐millimeter displacements
from film measurements. The studied system is thus sufficiently
accurate in the radiosurgical setting for routine semi‐empirical dose
reconstruction.
However, a bigger question remains on the role of calculations
vs. measurements in patient‐specific dosimetric QA. It is a subject of
ongoing debate,31 with the latest TG‐218 report29 acknowledging
but not adjudicating the issue. We characterize the approach
described in this paper as semi‐empirical or hybrid, as some of the
information (MLC apertures) is derived from independent measure-
ments, while other elements are harvested from the accelerator log
files. In addition to the delivered MLC leaf positons, such approach
(a) (b)
(c) (d)
(e)
(f)
F I G . 2 . Gamma maps and isodose
overlays for PF vs. film. (a&b): Oblique 45°
plane from Plan 1, (c&d): Oblique 135°
plane from Plan 5, and (e&f): Oblique 45°
plane from Plan 10.
TAB L E 3 Displacement between PF and film dose profiles centers in different anatomical directions.
Direction Craniocaudal Anteroposterior Lt‐Rt Obl. 45° Obl. 135°
No. analyzed 27 4 3 11 7
Δ ±1SD (mm) −0.3 ± 0.4 0.0 ± 0.6 −0.1 ± 0.4 −0.2 ± 0.7 0.0 ± 0.4
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definitively tests the integrity of the data transfer chain all the way
from the TPS to the accelerator, which is one of the most important
aspects of the patient‐specific end‐to‐end tests. The beam model
quality, which is the frequent culprit in the end‐to‐end head and
neck phantom irradiation failures32 is also tested, but not by direct
dose measurements. We would argue that this level of scrutiny is
acceptable for routine QA (as opposed to system commissioning),
and furthermore 3D reconstruction with small voxels is more com-
prehensive than, for example, experimental planar sampling with
large detector pitch arrays. Studying the sensitivity of the method to
induced MLC errors is outside the scope of this work, but it is likely
to be similar to the results demonstrated by others in the related
work with high‐resolution systems.33,34 While the risk of a false pos-
itive findings (an error reported when there is none) is easily miti-
gated by measurement if necessary, a potential false negative (no
error reported when there is one) is more likely to slip through. The
risk of accelerator absolute calibration changes after the morning
checkout has always been considered sufficiently mitigated in con-
ventional treatments by the redundancy of the dosimetry chain, and
the TG‐218 specifically recommends the IMRT QA measured dose
to be normalized to the daily output29 to exclude the influence of
the fluctuations, which could otherwise consume a substantial part
of the error budget. Thus, the remaining weakest link in the tested
PF configuration (and there are other options, not described in this
work) is the lack of independent verification of the accelerator axes
positions (fractional MU, gantry angle, etc.) other than the MLC. If
an accelerator fails in such a fashion that the log files reflect the
intended plan that diverges from the delivered treatment, a dosimet-
ric error may go unnoticed. It should be, however, argued that a ran-
dom accelerator failure during treatment by definition cannot be
reliably caught by pre-treatment measurements in the first place,
while any gradual parameter drift is more appropriately addressed by
an ongoing comprehensive QA program. Regarding systematic deliv-
ery deficiencies, with modern digital accelerators, the known issues
such as the overshoot phenomenon35 are largely considered miti-
gated.20 For example, for the TrueBeam accelerator with its 20 ms
controller interrogation cycle and strict delivery linearity enforce-
ment inside each control point,36 even the gantry acceleration trajec-
tory is highly predictable and reproducible.37 Therefore, while not
going as far as endorsing the log file analysis as a “premier SRS/SBRT
QA tool,”38 we nevertheless suggest that coupled with thorough
TPS commissioning and comprehensive ongoing accelerator QA pro-
gram, the hybrid verification method validated in this paper is a
viable tool that could be applied in clinical practice.
5. | CONCLUSIONS
A semi‐empirical volumetric dose verification system extracts MLC
positions from the EPID movies, while the rest of the delivery con-
trol point information comes from the accelerator log files. This
combination is used to reconstruct dose on a patient CT dataset
with a fast superposition/convolution algorithm. The method was
comprehensively validated for single‐isocenter multi‐target VMAT
SRS treatments against absolute film measurements. With proper
understanding of its advantages and shortcomings, the tool can be
used in routine clinical practice.
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